共 20 条
[1]
Collins R., Peto R., MacMahon S., Et al., Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context, Lancet, 335, pp. 827-838, (1990)
[2]
Cutler J.A., MacMahon S.W., Furberg C.D., Controlled clinical trials of drug treatment for hypertension. A review, Hypertension, 13, pp. I36-I44, (1989)
[3]
Efficacy of antihypertensive drug treatment according to age, sex, blood pressure, and previous cardiovascular disease in patients over the age of 60<sup>*</sup>, Lancet, 2, pp. 589-592, (1986)
[4]
Cameron H.A., Raay L.E., Ketanserin in essential hypertension: a double-blind, placebo-controlled study, Postgrad Med J, 61, pp. 583-586, (1985)
[5]
Prevention of atherosclerotic complications: controlled trial of ketanserin, Br Med J, 298, pp. 424-430, (1989)
[6]
Payer L., Medicine & Culture: Varieties of Treatment in the United States, England, West Germany, and France, (1988)
[7]
MRC trial of treatment of mild hypertension: Principal results, Br Med J, 291, pp. 97-104, (1985)
[8]
McVeigh G., Galloway D., Johnston D., The case for low dose diuretics in hypertension: comparison of low and conventional doses of cyclopenthiazide, Br Med J, 297, pp. 95-97, (1988)
[9]
Mortality and morbidity results from the European Working Party on high blood pressure in the elderly trial, Lancet, 1, pp. 1349-1354, (1985)
[10]
Floras J.S., Jones J.V., Hassan M.O., Et al., Cuff and ambulatory blood pressure in subjects with essential hypertension, Lancet, 2, pp. 107-109, (1981)